Filing Details

Accession Number:
0001127602-21-016094
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-10 13:00:00
Reporting Period:
2021-05-07
Accepted Time:
2021-05-10 17:13:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100682 Charles River Laboratories International Inc. CRL Services-Commercial Physical & Biological Research (8731) 061397316
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1141722 C James Foster 251 Ballardvale Street
Wilmington MA 01887
Chairman, President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-07 2,484 $341.80 221,088 No 4 S Direct
Common Stock Disposition 2021-05-07 1,102 $342.42 219,986 No 4 S Direct
Common Stock Disposition 2021-05-07 2,008 $343.55 217,978 No 4 S Direct
Common Stock Disposition 2021-05-07 1,300 $344.60 216,678 No 4 S Direct
Common Stock Disposition 2021-05-07 606 $345.85 216,072 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 19,013 Indirect 2019 GRAT
Common Stock 17,579 Indirect 2020 GRAT
Common Stock 340 Indirect By Trust
Common Stock 750 Indirect By Trust
Common Stock 2,250 Indirect By Trust
Common Stock 10,000 Indirect Held By Spouse
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $341.24 to $342.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This transaction was executed in multiple trades at prices ranging from $342.33 to $342.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $343.33 to $344.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $344.34 to $344.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $345.36 to $346.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. On 4/29/2021: 2,421 shares were transferred from the 2020 GRAT account to Direct Holdings.